Oxytocin availability and administration by facility type, country and first-phase follow-up
| Oxytocin availability | n (%) | ||
| Baseline 58 (82.9) | Follow-up 83 (97.6) | Total* 141 (91.0) | |
| EONC facility type | |||
| Basic level | 43 (84.3) | 61 (96.8) | 104 (91.2) |
| Comprehensive level | 15 (78.9) | 22 (100.0) | 37 (90.2) |
| Country | |||
| Belize | 4 (100.0) | 4 (100.0) | 8 (100.0) |
| Guatemala | 15 (88.2) | 22 (91.7) | 37 (90.2) |
| Honduras | 13 (92.9) | 12 (100.0) | 25 (96.2) |
| Mexico | 7 (100.0) | 14 (100.0) | 21 (75.0) |
| Nicaragua | 6 (85.7) | 14 (100.0) | 20 (95.2) |
| Panama | 13 (92.9) | 17 (100.0) | 30 (96.8) |
| Oxytocin administration for prevention of postpartum haemorrhage | n (%) | ||
| Baseline 771 (83.6) | Follow-up 1353 (88.4) | Total 2124 (86.6) | |
| EONC facility type | |||
| Basic level | 521 (84.6) | 852 (88.4) | 1373 (86.9) |
| Comprehensive level | 250 (81.7) | 501 (88.5) | 751 (86.1) |
| Country | |||
| Belize | 9 (64.3) | 72 (80.0) | 81 (77.9) |
| Guatemala | 198 (80.2) | 393 (91.0) | 591 (87.0) |
| Honduras | 224 (95.7) | 221 (94.8) | 445 (95.3) |
| Mexico | 129 (71.7) | 277 (82.9) | 406 (79.0) |
| Nicaragua | 87 (96.7) | 168 (82.8) | 255 (87.0) |
| Panama | 124 (79.0) | 222 (93.3) | 346 (87.6) |
*n may vary for each variable due to missingness.
EONC, essential obstetric and newborn care.